24 May 2013
Keywords: top, management, changes, curagen, due, firm, corp
Article | 23 May 2005
Due to US firm CuraGen Corp's majority-owned subsidiary 454 Life Sciences partnership with Roche, the former's founder and chief
executive, Jonathan ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 May 2005
23 May 2013
© 2013 thepharmaletter.com